Company Profile
Sophia Genetics Stock Price, News & Analysis
- Ticker:
- SOPH
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
5.72 USD (+1.24%)
Close
Last updated: July 13, 2026 at 00:00
474.01M USD
Market cap
Why the stock is moving
SOPH is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Sophia Genetics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Sophia Genetics is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Sophia Genetics follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Sophia Genetics sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 02
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
- 03
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
BMY · Source: BMYBristol-Myers Squibb Company
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Sophia Genetics (SOPH)?
Sophia Genetics (SOPH) most recently closed at 5.72 USD, a +1.24% move versus the previous session.
What is the market cap of Sophia Genetics (SOPH)?
Sophia Genetics currently has a market capitalization of 474.01M USD on BioPharmSignal.
What does Sophia Genetics do?
Sophia Genetics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is SOPH stock listed?
Sophia Genetics (SOPH) is associated with NASDAQ, United States, Biotechnology.
What is Sophia?
Sophia Genetics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Sophia Genetics targeting with Sophia?
Sophia Genetics is associated with genetic disease based on its company overview and current catalyst commentary.
What is Genetics?
Sophia Genetics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.